PD-L1 lncRNA splice isoform promotes lung adenocarcinoma progression via enhancing c-Myc activity
2021 · Genome biology · 75 citations
https://doi.org/10.1186/s13059-021-02331-0
J
Jiahan Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
313
Citations
7
h-index
7
i10-index
Jiahan Xu is an academic researcher from Wenzhou Medical University. The author has contributed to research in topics: RNA modifications and cancer & Acute Ischemic Stroke Management & Cancer-related molecular mechanisms research. The author has an h-index of 7, co-authored 12 publications.
Papers by this author
worksHuman lung adenocarcinoma CD47 is upregulated by interferon-γ and promotes tumor metastasis
2022 · Molecular Therapy — Oncolytics · 14 citations
https://doi.org/10.1016/j.omto.2022.04.011
Hepatic Fibrosis Predicts the Prognosis of Patients with Acute Ischemic Stroke Through the Mediation of Cardioembolism
2025 · Current Vascular Pharmacology · 1 citations
https://doi.org/10.2174/0115701611343296250218111614
PD-L1 lncRNA splice promotes lung adenocarcinoma progression via enhancing c-Myc activity
2020 · bioRxiv (Cold Spring Harbor Laboratory) · 0 citations
https://doi.org/10.1101/2020.09.29.282541
An integrative strategy combining network pharmacology, metabolomics, and gut microbiota analyses to elucidate the bioactive ingredients and underlying mechanisms of Xin-Shu-Ning tablets against myocardial ischemia
2026 · Journal of Pharmaceutical and Biomedical Analysis · 0 citations
https://doi.org/10.1016/j.jpba.2026.117419
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat